Schedule 13D ownership disclosure

ARGOS THERAPEUTICS INC

Security class unavailable · CUSIP: 040221103

Event date: 2016-03-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
9,108,234
Percent of class
34.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000904454-16-001143
Form type
SC 13D
Filer
ARGOS THERAPEUTICS INC
CIK
CIK 1105533
Filed
Mar 22, 2016
Reporting period
Mar 14, 2016
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub